Cargando…

Parity and risk of stomach cancer by sub-site: a national Swedish study

We investigated stomach cancer risk by anatomic sub-site in relation to parity, as a marker for higher exposure to sex hormones, in a case–control study, nested within a cohort of 2 406 439 Swedish women born in 1925 or later and followed from 1970 or age 30 until emigration, death, any cancer diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahmanyar, S, Lambe, M, Zendehdel, K, Nyrén, O, Boffetta, P, Ye, W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359643/
https://www.ncbi.nlm.nih.gov/pubmed/18382461
http://dx.doi.org/10.1038/sj.bjc.6604283
_version_ 1782152883245940736
author Bahmanyar, S
Lambe, M
Zendehdel, K
Nyrén, O
Boffetta, P
Ye, W
author_facet Bahmanyar, S
Lambe, M
Zendehdel, K
Nyrén, O
Boffetta, P
Ye, W
author_sort Bahmanyar, S
collection PubMed
description We investigated stomach cancer risk by anatomic sub-site in relation to parity, as a marker for higher exposure to sex hormones, in a case–control study, nested within a cohort of 2 406 439 Swedish women born in 1925 or later and followed from 1970 or age 30 until emigration, death, any cancer diagnosis, or through 2004, whichever occurred first. We identified 286 cardia and 2498 non-cardia stomach cancer cases with five matched controls for each case. Cross-linkage with the Multi-Generation Register provided information about reproductive history. Using conditional logistic regression models for estimating odds ratios (ORs) and corresponding 95% confidence intervals (CIs), adjusted for education level and occupation, we found no association between any aspect of parity and non-cardia stomach cancer (OR=1.01, 95% CI 0.89–1.15, comparing parous with nulliparous women). However, a 30% risk reduction for postmenopausal cardia cancer (OR=0.7, 95% CI 0.4–1.0) was noted among parous relative to nulliparous women and the risk for premenopausal cardia cancer fell with increasing number of children (P for trend=0.04). Our results indicate that exposure to female sex hormones does not protect against non-cardia stomach cancer and does not explain male predominance. The observed moderate inverse relationship between parity and cardia cancer may be mediated by non-hormonal factors and warrants further study.
format Text
id pubmed-2359643
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23596432009-09-10 Parity and risk of stomach cancer by sub-site: a national Swedish study Bahmanyar, S Lambe, M Zendehdel, K Nyrén, O Boffetta, P Ye, W Br J Cancer Epidemiology We investigated stomach cancer risk by anatomic sub-site in relation to parity, as a marker for higher exposure to sex hormones, in a case–control study, nested within a cohort of 2 406 439 Swedish women born in 1925 or later and followed from 1970 or age 30 until emigration, death, any cancer diagnosis, or through 2004, whichever occurred first. We identified 286 cardia and 2498 non-cardia stomach cancer cases with five matched controls for each case. Cross-linkage with the Multi-Generation Register provided information about reproductive history. Using conditional logistic regression models for estimating odds ratios (ORs) and corresponding 95% confidence intervals (CIs), adjusted for education level and occupation, we found no association between any aspect of parity and non-cardia stomach cancer (OR=1.01, 95% CI 0.89–1.15, comparing parous with nulliparous women). However, a 30% risk reduction for postmenopausal cardia cancer (OR=0.7, 95% CI 0.4–1.0) was noted among parous relative to nulliparous women and the risk for premenopausal cardia cancer fell with increasing number of children (P for trend=0.04). Our results indicate that exposure to female sex hormones does not protect against non-cardia stomach cancer and does not explain male predominance. The observed moderate inverse relationship between parity and cardia cancer may be mediated by non-hormonal factors and warrants further study. Nature Publishing Group 2008-04-08 2008-04-01 /pmc/articles/PMC2359643/ /pubmed/18382461 http://dx.doi.org/10.1038/sj.bjc.6604283 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Bahmanyar, S
Lambe, M
Zendehdel, K
Nyrén, O
Boffetta, P
Ye, W
Parity and risk of stomach cancer by sub-site: a national Swedish study
title Parity and risk of stomach cancer by sub-site: a national Swedish study
title_full Parity and risk of stomach cancer by sub-site: a national Swedish study
title_fullStr Parity and risk of stomach cancer by sub-site: a national Swedish study
title_full_unstemmed Parity and risk of stomach cancer by sub-site: a national Swedish study
title_short Parity and risk of stomach cancer by sub-site: a national Swedish study
title_sort parity and risk of stomach cancer by sub-site: a national swedish study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359643/
https://www.ncbi.nlm.nih.gov/pubmed/18382461
http://dx.doi.org/10.1038/sj.bjc.6604283
work_keys_str_mv AT bahmanyars parityandriskofstomachcancerbysubsiteanationalswedishstudy
AT lambem parityandriskofstomachcancerbysubsiteanationalswedishstudy
AT zendehdelk parityandriskofstomachcancerbysubsiteanationalswedishstudy
AT nyreno parityandriskofstomachcancerbysubsiteanationalswedishstudy
AT boffettap parityandriskofstomachcancerbysubsiteanationalswedishstudy
AT yew parityandriskofstomachcancerbysubsiteanationalswedishstudy